American Association for Cancer Research

SHERPA: Unknown

People

  1. Razavi
    Razavi
  2. Chandarlapaty
    Chandarlapaty
  3. Reis-Filho
    Reis-Filho
  4. Scaltriti
    Scaltriti
  5. Robson
    Robson
  6. Selenica
    Selenica
  7. Brown
    Brown
  8. Drago
    Drago
  9. Hyman
    Hyman
  10. Jhaveri
    Jhaveri

Groups

  1. Breast Medicine Service (30)
  2. Department of Medicine (30)
  3. Solid Tumor Oncology Division (30)
  4. Weinberg Fellows (30)
  5. GSK Faculty (28)
  6. Human Oncology and Pathogenesis Program (25)
  7. Sloan Kettering Institute Postdocs (21)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (19)
  9. Department of Pathology and Laboratory Medicine (16)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (13)
Search Within
  1. "Pedram Razavi"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (4)
Groups
  1. Breast Medicine Service (30)
  2. Department of Medicine (30)
  3. Solid Tumor Oncology Division (30)
  4. Weinberg Fellows (30)
  5. GSK Faculty (28)
  6. Human Oncology and Pathogenesis Program (25)

More Groups

People
  1. Pedram Razavi (30)
  2. Sarat Chandarlapaty (16)
  3. Jorge Reis-Filho (13)
  4. Maurizio Scaltriti (11)
  5. Eneda Toska (6)
  6. Mark Robson (6)

More People

Years
  1. 2022 (6)
  2. 2021 (1)
  3. 2020 (14)
  4. 2019 (6)
  5. 2018 (2)
  6. 2016 (1)
Publications
  1. Cancer Research (26)
  2. Clinical Cancer Research (4)

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NR2F2 mediates cell growth and endocrine resistance in NF1 loss, ER+ breast cancer
    Meeting Abstract

    Cai, Y.; Zhao, P.; Wu, F.; Shao, H.; Razavi, P.; Xu, G.; Scaltriti, M.; Chandarlapaty, S.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Morphologic and genomic characteristics of breast cancers occurring in individuals with Lynch syndrome
    Journal Article

    Schwartz, C. J.; da Silva, E. M.; Marra, A.; Gazzo, A. M.; Selenica, P.; Rai, V. K.; Mandelker, D.; Pareja, F.; Misyura, M.; D'Alfonso, T. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic alterations in PIK3CA-mutated breast cancer result in mTORC1 activation and limit the sensitivity to PI3Kα inhibitors
    Journal Article

    Cai, Y.; Xu, G.; Wu, F.; Michelini, F.; Chan, C.; Qu, X.; Selenica, P.; Ladewig, E.; Castel, P.; Cheng, Y.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: